NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Park Medi World Share Price Falls 0.52% to ₹234 Amid Initial Gains on Thursday

On Thursday, 30 April, the share price of healthcare company Park Medi World turned red, falling by 0.52% to ₹234 apiece on the National Stock Exchange (NSE). The company's stock had initially gained in the early morning session, opening at ₹235 per share, slightly below its previous close of ₹235.15.

During the intraday session, Park Medi World's stock initially traded in the red, but briefly recovered to trim losses. However, it slipped back into negative territory during the session. According to data available on NSE, around 0.93 lakhs shares changed hands during the intraday session on 30 April, as of 10:55 am.

Brokerage FirmRatingTarget PriceUpside Potential
Choice Institutional EquitiesBuy₹32036%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The initial stock rally came after brokerage firm Choice Institutional Equities initiated coverage on the stock with a 'buy' rating of ₹320 apiece, with an upside potential up to 36%. The firm expects Park Medi World's revenue, EBITDA, and PAT to expand at a compound annual growth rate (CAGR) of 26.3%, 27.1%, and 34.6% over the fiscal years 2026-2029.

Park Medi World's recent business updates have been positive, with the company announcing the opening of a new multi-super specialty hospital in Panchkula on 10 April. The hospital represents a significant expansion in Northern India and aims to improve access to advanced tertiary and quaternary healthcare services across the Tricity region.

The Panchkula hospital is equipped with advanced diagnostic systems, modular operation theatres, and extensive critical care infrastructure. It will offer services across key specialties, including oncology, neurosciences, orthopedics, cardiology, and robotic-assisted surgeries. The launch comes alongside the ongoing development of the company's Mohali unit, strengthening its footprint in the region.

FacilityLocationCapacity
Panchkula HospitalPanchkula850 beds
Mohali UnitMohali(in development)

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Park Medi World operates 16 hospitals with a combined capacity of 3,960 beds. The company is also adding five new hospitals and expanding existing ones, which is expected to increase its total capacity to 5,460 beds by March 2028.

Despite weak market sentiments, Park Medi World's share price has remained positive. The stock has delivered 2.39% gains in a week, 23.28% gains in a month, and 56% in a year-to-date basis, outperforming broader market levels. According to Anshul Jain, Head of Research at Lakshmishree, Park Medi has delivered a strong structural move, breaking out twice from its IPO base and continuing to trend higher toward the second base target of ₹255.

Investor Takeaway

Park Medi World's share price fell 0.52% to ₹234 apiece on NSE, despite initial gains.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.